A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Clinical trial NCT06904261 · RECRUITING
Trial details
- NCT number
- NCT06904261
- Sponsor
- Amicus Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-08
- Primary completion
- 2027-12-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.